TRIAL DETAIL
Multiple Ascending Dose Study of BMS-754807 in Patients With Solid Tumors in Japan
Drug: |
||||
|---|---|---|---|---|
Trial Name: |
Multiple Ascending Dose Study of BMS-754807 in Patients With Solid Tumors in Japan |
|||
NCT#: |
||||
Conditions: |
Solid Tumors |
|||
Status: |
Completed |
|||
Phase: |
1 |
Start Date 07/01/2009 |
Age of Trial (yrs) 14.8 |
|
Treatment Phase: |
Gleevec-resistant |
|||
Drug Category: |
IGF1R inhibitor |
|||
Strategy: |
Block related tumor signal paths |
|||
Trial Type: |
GIST not specified. GIST patient enrollment unknown. |
|||
Other Protocol IDs: |
CA191-003 |
|||
Sponsor: |
Bristol-Myers Squibb |
|||
Patient Contact: |
Clinical.Trials@bms.com
|
|||
Contact email: |
||||
Contact Phone: |
||||
Randomized: |
||||
IV or Oral: |
Oral |
|||
Trial Notes: |
||||
Trial Links |
Trial Results |
Drug Information |
Trial Sites
Name |
Address |
City |
State |
Zip |
Country |
Tokyo |
104-0045 |
Japan |